Redefining obesity in the context of MASLD
- 6 August 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
Abstract
Was not provided for this article.Keywords
This publication has 8 references indexed in Scilit:
- Implications of new obesity definitions in the classification and outcomes of patients with MASLDHepatology, 2026
- Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): A Population‐Based Cohort StudyAlimentary Pharmacology & Therapeutics, 2025
- Metabolic dysfunction-associated steatotic liver disease in adultsNature Reviews Disease Primers, 2025
- Definition and diagnostic criteria of clinical obesityThe Lancet Diabetes & Endocrinology, 2025
- Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatmentThe Lancet Diabetes & Endocrinology, 2024
- A new framework for the diagnosis, staging and management of obesity in adultsNature Medicine, 2024
- The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic reviewHepatology, 2023
- Causes, consequences, and treatment of metabolically unhealthy fat distributionThe Lancet Diabetes & Endocrinology, 2020